NASDAQ:IRMD IRadimed - IRMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IRadimed Co. Please log in to your account or sign up in order to add this asset to your watchlist. $38.58 +0.55 (+1.45%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$37.30▼$38.9250-Day Range$30.52▼$42.1452-Week Range$26.00▼$55.92Volume45,435 shsAverage Volume43,532 shsMarket Capitalization$485.79 millionP/E Ratio37.83Dividend YieldN/APrice Target$48.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability IRadimed MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside24.4% Upside$48.00 Price TargetShort InterestN/ADividend StrengthN/ASustainability-0.85Upright™ Environmental ScoreNews Sentiment0.21Based on 5 Articles This WeekInsider TradingSelling Shares$2.06 M Sold Last QuarterProj. Earnings Growth17.09%From $1.17 to $1.37 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.15 out of 5 starsMedical Sector165th out of 995 stocksSurgical & Medical Instruments Industry13th out of 103 stocks 1.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $48.00, IRadimed has a forecasted upside of 24.4% from its current price of $38.59.Amount of Analyst CoverageIRadimed has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for IRMD. Previous Next 0.0 Dividend Strength Dividend YieldIRadimed does not currently pay a dividend.Dividend GrowthIRadimed does not have a long track record of dividend growth. Previous Next 4.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreIRadimed has received a 67.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Real-time vital parameter monitors for MRI machines", "Intravenous therapy equipment for MRI machines", and "ECG monitors" products. See details.Environmental SustainabilityThe Environmental Impact score for IRadimed is -0.85. Previous Next 2.3 News and Social Media Coverage News SentimentIRadimed has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for IRadimed this week, compared to 1 article on an average week.Search Interest9 people have searched for IRMD on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added IRadimed to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IRadimed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,055,287.00 in company stock.Percentage Held by Insiders43.70% of the stock of IRadimed is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions50.03% of the stock of IRadimed is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for IRadimed are expected to grow by 17.09% in the coming year, from $1.17 to $1.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IRadimed is 37.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.99.Price to Earnings Ratio vs. SectorThe P/E ratio of IRadimed is 37.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 113.47.Price to Book Value per Share RatioIRadimed has a P/B Ratio of 6.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About IRadimed (NASDAQ:IRMD) StockIRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. It also provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Read More Receive IRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter. Email Address IRMD Stock News HeadlinesMarch 27, 2023 | finance.yahoo.comWith 43% ownership, IRadimed Corporation (NASDAQ:IRMD) insiders have a lot at stakeMarch 22, 2023 | americanbankingnews.comIRadimed Co. (NASDAQ:IRMD) CEO Roger E. Susi Sells 10,000 SharesMarch 27, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.March 22, 2023 | americanbankingnews.comIRadimed (NASDAQ:IRMD) vs. Akili (NASDAQ:AKLI) Financial ComparisonMarch 17, 2023 | americanbankingnews.comRoger E. Susi Sells 10,000 Shares of IRadimed Co. (NASDAQ:IRMD) StockMarch 6, 2023 | finance.yahoo.comIRADIMED CORPORATION To Present at the 35th Annual Roth ConferenceFebruary 27, 2023 | finance.yahoo.comIradimed Notifies Potential Issue With Certain Syringe Adapter Sets During UseFebruary 24, 2023 | finance.yahoo.comIRADIMED CORPORATION Issues Urgent Medical Device CorrectionMarch 27, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …February 6, 2023 | finance.yahoo.comWinter Springs MRI tech firm Iradimed buys Orlando land for new manufacturing plantFebruary 2, 2023 | finance.yahoo.comIRadimed (IRMD) Q4 Earnings Top EstimatesJanuary 26, 2023 | finance.yahoo.comIRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2ndJanuary 20, 2023 | finance.yahoo.comShareholders Would Enjoy A Repeat Of IRadimed's (NASDAQ:IRMD) Recent Growth In ReturnsJanuary 18, 2023 | finance.yahoo.comIRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022January 6, 2023 | finance.yahoo.comShould You Be Adding IRadimed (NASDAQ:IRMD) To Your Watchlist Today?January 3, 2023 | reuters.comIRMD.A - Iradimed Corp | Stock Price & Latest News | ReutersDecember 7, 2022 | finance.yahoo.comWill Weakness in IRadimed Corporation's (NASDAQ:IRMD) Stock Prove Temporary Given Strong Fundamentals?November 29, 2022 | finance.yahoo.comHere is Why Growth Investors Should Buy iRadimed (IRMD) NowNovember 9, 2022 | finance.yahoo.comIRadimed Third Quarter 2022 Earnings: Beats ExpectationsNovember 7, 2022 | finance.yahoo.comInvesting in IRadimed (NASDAQ:IRMD) five years ago would have delivered you a 113% gainNovember 3, 2022 | finance.yahoo.comIRADIMED CORPORATION Announces Third Quarter 2022 Financial ResultsOctober 27, 2022 | finance.yahoo.comIRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rdOctober 18, 2022 | finance.yahoo.comIn spite of recent selling, insiders still control 43% of IRadimed Corporation (NASDAQ:IRMD)October 17, 2022 | benzinga.com2022 Infusion Pumps and Devices Technology and Global Markets Report with Profiles of Leading Players - I - BenzingaOctober 15, 2022 | nasdaq.comShould You Think About Buying IRadimed Corporation (NASDAQ:IRMD) Now? - NasdaqOctober 10, 2022 | finance.yahoo.com3 REITs With Dividends Above 8% - Yahoo FinanceOctober 10, 2022 | finance.yahoo.comIradimed Withdraws FDA Application For Updated MR IV Pump SystemSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRadimed and its competitors with MarketBeat's FREE daily newsletter. Email Address IRMD Company Calendar Last Earnings2/02/2023Ex-Dividend for 2/21 Dividend2/10/2023Dividend Payable2/21/2023Today3/27/2023Next Earnings (Estimated)5/05/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRMD CUSIPN/A CIK1325618 Webwww.iradimed.com Phone(407) 677-8022Fax407-677-5037Employees110Year FoundedN/APrice Target and Rating Average Stock Price Forecast$48.00 High Stock Price Forecast$48.00 Low Stock Price Forecast$48.00 Forecasted Upside/Downside+26.7%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)$1.02 Trailing P/E Ratio37.14 Forward P/E Ratio32.38 P/E GrowthN/ANet Income$12.83 million Net Margins23.99% Pretax Margin30.36% Return on Equity18.81% Return on Assets16.33% Debt Debt-to-Equity RatioN/A Current Ratio9.06 Quick Ratio8.43 Sales & Book Value Annual Sales$53.30 million Price / Sales8.95 Cash Flow$1.07 per share Price / Cash Flow35.42 Book Value$5.86 per share Price / Book6.46Miscellaneous Outstanding Shares12,590,000Free Float7,090,000Market Cap$476.91 million OptionableNot Optionable Beta1.03 Key ExecutivesRoger SusiChairman, President & Chief Executive OfficerJohn F. GlennChief Financial Officer & SecretaryChris WilliamsonVice President-Information TechnologyLynn NeuhardtVice President-Research & DevelopmentRandy WaddellVP-Worldwide Sales & MarketingKey CompetitorsApollo EndosurgeryNASDAQ:APENArtivionNYSE:AORTAngioDynamicsNASDAQ:ANGOPulmonxNASDAQ:LUNGLiquidiaNASDAQ:LQDAView All CompetitorsInsiders & InstitutionsRoger E SusiSold 10,000 sharesTotal: $374,500.00 ($37.45/share)Roger E SusiSold 10,000 sharesTotal: $378,100.00 ($37.81/share)Roger E SusiSold 5,484 sharesTotal: $211,243.68 ($38.52/share)Roger E SusiSold 9,763 sharesTotal: $368,943.77 ($37.79/share)Roger E SusiSold 10,000 sharesTotal: $367,500.00 ($36.75/share)View All Insider TransactionsView All Institutional Transactions IRMD Stock - Frequently Asked Questions What is IRadimed's stock price forecast for 2023? 0 analysts have issued 12 month target prices for IRadimed's stock. Their IRMD share price forecasts range from $48.00 to $48.00. On average, they anticipate the company's share price to reach $48.00 in the next twelve months. This suggests a possible upside of 26.7% from the stock's current price. View analysts price targets for IRMD or view top-rated stocks among Wall Street analysts. How have IRMD shares performed in 2023? IRadimed's stock was trading at $28.29 on January 1st, 2023. Since then, IRMD stock has increased by 33.9% and is now trading at $37.88. View the best growth stocks for 2023 here. When is IRadimed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023. View our IRMD earnings forecast. How were IRadimed's earnings last quarter? IRadimed Co. (NASDAQ:IRMD) announced its earnings results on Thursday, February, 2nd. The medical equipment provider reported $0.29 earnings per share for the quarter, hitting the consensus estimate of $0.29. The medical equipment provider earned $14.86 million during the quarter, compared to analysts' expectations of $14.93 million. IRadimed had a trailing twelve-month return on equity of 18.81% and a net margin of 23.99%. How often does IRadimed pay dividends? What is the dividend yield for IRadimed? IRadimed announced a dividend on Monday, February 6th. Investors of record on Monday, February 13th will be paid a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is an increase from the stock's previous dividend of $1.00. Read our dividend analysis for IRMD. What ETF holds IRadimed's stock ? Ballast Small/Mid Cap ETF holds 16,660 shares of IRMD stock, representing 0.91% of its portfolio. What guidance has IRadimed issued on next quarter's earnings? IRadimed updated its fourth quarter 2022 earnings guidance on Wednesday, January, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.90 million-$14.90 million, compared to the consensus revenue estimate of $14.63 million. What other stocks do shareholders of IRadimed own? Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR). What is IRadimed's stock symbol? IRadimed trades on the NASDAQ under the ticker symbol "IRMD." Who are IRadimed's major shareholders? IRadimed's stock is owned by a variety of institutional and retail investors. Top institutional investors include Soleus Capital Management L.P. (5.93%), Renaissance Technologies LLC (4.73%), Bares Capital Management Inc. (2.16%), Russell Investments Group Ltd. (1.61%), Dimensional Fund Advisors LP (1.28%) and Geode Capital Management LLC (1.07%). Insiders that own company stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi. View institutional ownership trends. How do I buy shares of IRadimed? Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is IRadimed's stock price today? One share of IRMD stock can currently be purchased for approximately $37.88. How much money does IRadimed make? IRadimed (NASDAQ:IRMD) has a market capitalization of $476.91 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.02 on an earnings per share basis. How many employees does IRadimed have? The company employs 110 workers across the globe. How can I contact IRadimed? IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037. This page (NASDAQ:IRMD) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.